Correction to “Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?”
PPAR Research · 2026-01 · 2026 (1)
DOI: 10.1155/ppar/9796467 ↗Kurz gefasst
Korrektur in der Zeitschrift PPAR Research, online erschienen am 01.07.2026. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
C. Cilibrasi, V. Butta, G. Riva, and A. Bentivegna, “Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?,” PPAR Research, vol. 2016 (2016). https://doi.org/10.1155/2016/7175067. In the article titled “Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?,” there was an error in Figure 5. Specifically, an incorrect image was selected for the cells in the control group stained for CD133/IP/Ph as it represents untreated GliNS2 cells stained for CD133 as reported in a previous publication by the same author group [1]. The error was introduced by the authors during figure assembly and Figure 5 should be corrected as follows: We apologize for these errors.
Zitieren
APA
(2026). Correction to “Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?”. PPAR Research, 2026(1). https://doi.org/10.1155/ppar/9796467
Vancouver
Correction to “Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?”. PPAR Research. 2026;2026(1). doi:10.1155/ppar/9796467
BibTeX
@article{euvimed2026,
title = {Correction to “Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?”},
journal = {PPAR Research},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ppar/9796467}
}
EUVIMED